No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CNK240621C18000
- 1.31
- -0.54-29.19%
15min DelayClose Jun 20 16:00 ET
1.98High1.10Low
1.98Open1.85Pre Close11 Volume5.31K Open Interest18.00Strike Price1.40KTurnover96.87%IV-0.41%PremiumJun 21, 2024Expiry Date1.39Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9288Delta0.1356Gamma13.61Leverage Ratio-0.0349Theta0.0005Rho12.64Eff Leverage0.0014Vega
Intraday
- 5D
- Daily
News
Heard on the Street: Summer Box Office Needs More Big Scores -- WSJ
By Dan Gallagher Movie-theater stocks are finally feeling some summer heat. But even the strong success of two recent blockbusters is leaving a big gap to fill. Disneys Inside Out 2 scored $154.2 mi
Cinemark Is Maintained at Outperform by Barrington Research
Cinemark Is Maintained at Outperform by Barrington Research
Cinemark Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 26.62% Barrington Research $24 → $24 Maintains Outperform 05/06/2024 26.62% Barrington Research
'Inside Out 2' Is a Blockbuster. Are Movie Chains Finally Back? -- Barrons.com
By Paul R. La Monica Walt Disney's "Inside Out 2" blowout opening just might give investors in movie theater stocks more reason for joy than anger, fear, sadness and disgust. And that's not a rundow
Barrington Maintains Cinemark(CNK.US) With Buy Rating, Maintains Target Price $24
Barrington analyst James Goss maintains $Cinemark(CNK.US)$ with a buy rating, and maintains the target price at $24.According to TipRanks data, the analyst has a success rate of 0.0% and a total avera
Slowing Rates Of Return At Cinemark Holdings (NYSE:CNK) Leave Little Room For Excitement
Comments
Morning Movers
Gapping up
$ShockWave Medical(SWAV.US$ stock rose 1.6% after Johnson & Johnson announced it would buy the company for $12.5 billion. The transaction would boost J&J’s portfolio of cardiovascular disease treatment devices.
$Krispy Kreme(DNUT.US$ stock rose 5.3% after Piper Sandler upgraded its stance on the doughnut chain to 'overweight' from 'neutral’, saying its national partnership with McDonald’s (NYSE:MCD) could...
Gapping up
$ShockWave Medical(SWAV.US$ stock rose 1.6% after Johnson & Johnson announced it would buy the company for $12.5 billion. The transaction would boost J&J’s portfolio of cardiovascular disease treatment devices.
$Krispy Kreme(DNUT.US$ stock rose 5.3% after Piper Sandler upgraded its stance on the doughnut chain to 'overweight' from 'neutral’, saying its national partnership with McDonald’s (NYSE:MCD) could...
48
1
$Cinemark(CNK.US$ Sympathy tank incoming. AMC type plunge.
1
Cinemark Holdings' declining returns suggest it may be a mature business with limited growth in the last five years. If trends persist, it's unlikely to become a multi-bagger. Considering these trends, exploring other investment options may be advisable.
1
$Cinemark(CNK.US$
good to see cnk stock not so manipulated like amc ….
good to see cnk stock not so manipulated like amc ….
2
Read more
Justin Brewer : Makes me want to play right away.
Up, up, down, down, left, right, left, right, B, A, start… 30 men and the WIN!